Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01095848 | A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer | completed | Phase 1 | 23 | ImmunoVaccine Technologies, Inc. (IMV Inc.)INDUSTRY | 1 | Dec 15, 2015 | clinicaltrials |
| NCT00667537 | PK in Pts With HRPC & Skeletal Metastes | completed | Phase 1 | 6 | BayerINDUSTRY | 1 | Dec 14, 2015 | clinicaltrials |
| NCT00652210 |
| Use of Multiphoton Microscopy in the Diagnosis of Cancer(MPM) |
| completed |
| Phase 1 |
| 344 |
| Weill Medical College of Cornell UniversityOTHER |
| 1 |
| Dec 10, 2015 |
| clinicaltrials |
| NCT00450229 | Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Dec 4, 2015 | clinicaltrials |
| NCT01172028 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | University of ArizonaOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT01261754 | A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers | completed | Phase 1 | 16 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01572701 | Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection | completed | Phase 1 | 8 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01615406 | A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer | completed | Phase 1 | 9 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01654874 | 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404 | completed | Phase 1 | 6 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2015 | clinicaltrials |
| NCT02396368 | A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer(Radium-223) | withdrawn | Phase 1 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00969202 | Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer | unknown | Phase 1 | 50 | San Diego RadiosurgeryINDUSTRY | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00928174 | Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer | completed | Phase 1 / Phase 2 | 27 | Queen's Medical CenterOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT01685489 | A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer | withdrawn | Phase 1 | 0 | Bastyr UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT00872157 | BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 23, 2015 | clinicaltrials |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | terminated | Phase 1 / Phase 2 | 79 | Otsuka Novel Products GmbHINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT01229618 | Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer | completed | Phase 1 | 31 | University of California, San FranciscoOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT02338700 | Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient | completed | Phase 1 / Phase 2 | 20 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 10, 2015 | clinicaltrials |
| NCT02437539 | Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography(uPAR-PET) | completed | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Aug 24, 2015 | clinicaltrials |
| NCT01897207 | Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 15 | Cantonal Hospital of St. GallenOTHER | 0 | Aug 17, 2015 | clinicaltrials |
| NCT00514267 | An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors | completed | Phase 1 / Phase 2 | 32 | Astellas Pharma IncINDUSTRY | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02502994 | Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC | unknown | Phase 1 | 12 | Norio NonomuraOTHER | 1 | Jul 20, 2015 | clinicaltrials |
| NCT01436214 | Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer | unknown | Phase 1 / Phase 2 | 60 | Adamis Pharmaceuticals CorporationINDUSTRY | 1 | Jul 16, 2015 | clinicaltrials |
| NCT00250224 | Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II | completed | Phase 1 | 100 | Aalborg University HospitalOTHER | 1 | Jun 26, 2015 | clinicaltrials |
| NCT00327288 | Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients | completed | Phase 1 | 34 | AmpliMed CorporationINDUSTRY | 1 | Jun 24, 2015 | clinicaltrials |
| NCT02049190 | Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 75 | Arno TherapeuticsINDUSTRY | 1 | Jun 24, 2015 | clinicaltrials |
| NCT00178113 | A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia | completed | Phase 1 | 80 | University of PittsburghOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT00743379 | Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 71 | Threshold PharmaceuticalsINDUSTRY | 1 | May 7, 2015 | clinicaltrials |
| NCT00019344 | Flavopiridol in Treating Patients With Refractory Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00302471 | MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011) | completed | Phase 1 | 29 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 27, 2015 | clinicaltrials |
| NCT00450957 | Lycopene in Healthy Male Participants | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00585637 | Vitamin D for Chemoprevention | completed | Phase 1 | 328 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 1, 2015 | clinicaltrials |
| NCT00010231 | Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | 22 | University of PittsburghOTHER | 1 | Mar 30, 2015 | clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT00023634 | S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer | terminated | Phase 1 | 14 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 6, 2015 | clinicaltrials |
| NCT01163448 | Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer | withdrawn | Phase 1 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT01565512 | Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort | withdrawn | Phase 1 / Phase 2 | 0 | Columbia UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT00441337 | A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies(MDX1106-01) | completed | Phase 1 | 39 | Bristol-Myers SquibbINDUSTRY | 1 | Feb 20, 2015 | clinicaltrials |
| NCT01790451 | Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans | completed | Phase 1 | 16 | Clinical Research Office of the Endourological SocietyOTHER | 1 | Feb 20, 2015 | clinicaltrials |
| NCT02055716 | Sulforadex in Healthy Human Males MAD | completed | Phase 1 | 18 | Evgen PharmaINDUSTRY | 1 | Feb 10, 2015 | clinicaltrials |
| NCT00539968 | A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) | terminated | Phase 1 / Phase 2 | 5 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 5, 2015 | clinicaltrials |
| NCT00631527 | Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | completed | Phase 1 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 29, 2015 | clinicaltrials |
| NCT00151086 | Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 33 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 22, 2015 | clinicaltrials |
| NCT00913263 | An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate(2-HOF) | completed | Phase 1 / Phase 2 | 24 | Lidds ABINDUSTRY | 1 | Jan 19, 2015 | clinicaltrials |
| NCT00511576 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | terminated | Phase 1 | 54 | Mirati Therapeutics Inc.INDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01324583 | Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer | completed | Phase 1 | 48 | SanofiINDUSTRY | 1 | Jan 7, 2015 | clinicaltrials |
| NCT01497431 | Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Nov 26, 2014 | clinicaltrials |
| NCT01610050 | A Phase I Study of LFA102 in Japanese Patients | completed | Phase 1 | 14 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 11, 2014 | clinicaltrials |
| NCT00753220 | Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer(CRITICAL) | terminated | Phase 1 / Phase 2 | 7 | Bostwick LaboratoriesINDUSTRY | 1 | Nov 4, 2014 | clinicaltrials |
| NCT01320787 | 18-F-Fluoroacetate as PET Imaging Agent | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 23, 2014 | clinicaltrials |
| NCT01009736 | Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy | completed | Phase 1 / Phase 2 | 60 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 16, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Dec 15, 2015source: clinicaltrials